Why diversity is needed at every level of clinical trials, from participants to leaders

Nat Med. 2024 Apr;30(4):929. doi: 10.1038/s41591-024-02914-x.

Author

Khadijah Breathett¹

Affiliation

¹ Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN, USA. kbreath@iu.edu.

PMID: 38605167
DOI: 10.1038/s41591-024-02914-x

No abstract available